Are all gonadotrophin‐releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review
Sign Up to like & getrecommendations! Published in 2018 at "BJU International"
DOI: 10.1111/bju.14168
Abstract: To review direct comparative studies of the gonadotrophin‐releasing hormone (GnRH) agonists goserelin, triptorelin, and leuprorelin for the treatment of prostate cancer, and identify whether there are meaningful clinical differences between these agents. In June 2017,… read more here.
Keywords: prostate; releasing hormone; gonadotrophin releasing; prostate cancer ... See more keywords
Gonadotrophin‐releasing hormone receptor autoantibodies induce polycystic ovary syndrome‐like features in a rat model
Sign Up to like & getrecommendations! Published in 2021 at "Experimental Physiology"
DOI: 10.1113/ep089109
Abstract: What is the central question of this study? Is there a causal relationship between gonadotrophin‐releasing hormone (GnRH) receptor‐activating autoantibodies and polycystic ovary syndrome (PCOS)? What is the main finding and its importance? Induction of GnRH… read more here.
Keywords: polycystic ovary; receptor; ovary syndrome; releasing hormone ... See more keywords